SYS ONLINE
SUPPLEMENT_SCHOLAR
evidence · mechanism · dose
Supplements/Peptide

TB-500 (Thymosin Beta-4)

Synthetic thymosin fragment for tissue repair.

Skin, Hair & Nails

Overview

Synthetic thymosin fragment for tissue repair.

Natural sources
    Common forms

      Mechanism of action

      Sequesters G-actin, promotes angiogenesis and cell migration.

      Pathways

        Effects on the body

        Organ system effects

        Evidence-based benefits

        Accelerates wound healing

        Moderate evidence

        Potential side effects

        Common
        • · Injection site pain
        Rare
          Serious

            Drug interactions

            No notable interactions reported.

            Safety & non-supplemental interactions

            Educational summary — always confirm with your clinician or pharmacist before starting, stopping, or combining with prescription therapy.

            Avoid if you are
            • ·Pregnant or breastfeeding (insufficient safety data)
            • ·Children under 18 (unless directed by a clinician)
            Other notes
            • ·Most research peptides are not FDA-approved for human use outside investigational protocols.

            Supplement interactions

            Pairs well with

            None listed.

            Avoid combining with

            No specific avoidances listed.

            Dosing & bioavailability

            Typical dose
            2 mg subcutaneous twice weekly

            Where to buy

            Affiliate-style search links to reputable retailers. We don't endorse specific brands — verify third-party testing (USP, NSF, Informed Sport) before purchase.

            Peptide
            TB-500 (Thym…
            Amazon
            Wide selection · fast shipping
            Peptide
            TB-500 (Thym…
            iHerb
            Global delivery · curated brands
            Peptide
            TB-500 (Thym…
            Thorne
            Practitioner-grade · NSF tested

            Scientific evidence (8)

            AnimalJ Invest Dermatol · 1999

            Thymosin beta-4 in wound healing

            Malinda KM, et al.

            Rat wound model

            Key findings

            Accelerated wound closure 42%.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: TB-500 (Thymosin Beta-4) — Accelerates wound healing

            Live PubMed search

            Live results for "TB-500 (Thymosin Beta-4) Accelerates wound healing" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "Accelerates wound healing". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: TB-500 (Thymosin Beta-4) — randomized controlled trial

            Live PubMed search

            Live results for "TB-500 (Thymosin Beta-4) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: TB-500 (Thymosin Beta-4) — meta-analysis

            Live PubMed search

            Live results for "TB-500 (Thymosin Beta-4) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: TB-500 (Thymosin Beta-4) — pharmacokinetics

            Live PubMed search

            Live results for "TB-500 (Thymosin Beta-4) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: TB-500 (Thymosin Beta-4) — safety adverse events

            Live PubMed search

            Live results for "TB-500 (Thymosin Beta-4) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewPubMed (NLM) · 1970

            PubMed: TB-500 (Thymosin Beta-4) — dose response

            Live PubMed search

            Live results for "TB-500 (Thymosin Beta-4) dose response" across the PubMed/MEDLINE peer-reviewed index.

            Key findings

            Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

            Open study
            Systematic reviewGoogle Scholar · 1970

            Google Scholar: TB-500 (Thymosin Beta-4) — clinical evidence

            Live Scholar search

            Cross-database citation index for TB-500 (Thymosin Beta-4) as it relates to "clinical evidence".

            Key findings

            Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

            Open study
            Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.